HSCS Heart Test Laboratories
- 0.0953
- -0.0021-2.16%
Heart Test Laboratories News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
HeartSciences Says European Patent Office Application EP3834729 Has Been Granted
HeartSciences Says European Patent Office Application EP3834729 Has Been Granted
HeartSciences to Present at the LD Micro Invitational XIV Conference
Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LVDD Can Be RecommendedSouthlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a
Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 Loss per Share (Vs US$0.16 Loss in 3Q 2023)
Heart Test Laboratories Reports Q3 Results
Heart Test Laboratories Cash And Cash Equivalents As Of Jan. 31 Were ~$7.1M
Heart Test Laboratories Cash And Cash Equivalents As Of Jan. 31 Were ~$7.1M
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Southlake, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients With Type 2 Diabetes
Data Demonstrated MyoVista AI-ECG model significantly outperformed NT-proBNP and ARIC HF score, the conventional standards of care for Stage B Heart Failure screeningSouthlake, Texas, March 12, 2024
Dow Jumps 200 Points; Abercrombie & Fitch Posts Upbeat Profit
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.54% to 38,791.96 while the NASDAQ rose 0.
HeartSciences Announces Canada Patent Grant Covering MyoVista Wavelet Technology
HeartSciences Announces Canada Patent Grant Covering MyoVista Wavelet Technology
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) shares increased by 69.4% to $1.46 during Wednesday's pre-market session. The market value of their outstanding shares is at $31.9 million. Creative Medical Tech (NA
Heart Test Laboratories: Selling Stockholders May Offer Up to 34.7M Shrs From Time to Time
Heart Test Laboratories: Selling Stockholders May Offer Up to 34.7M Shrs From Time to Time
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) stock increased by 62.4% to $1.4 during Tuesday's after-market session. The company's market cap stands at $30.6 million. vTv Therapeutics (NASDAQ:VTVT) stock moved
HeartSciences Adds Key Advisor to Its Scientific Advisory Board
Southlake, TX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered m
HeartSciences Expands Its Scientific Advisory Board
Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered m
HeartSciences Appoints New Scientific Advisory Board Member
Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered m
Heart Test Laboratories Shareholders Annual Voting Outcomes
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
Southlake, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered m
12 Health Care Stocks Moving In Friday's After-Market Session
GainersHeart Test Laboratories (NASDAQ:HSCS) stock moved upwards by 41.6% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. MyMD Pharmace
Analysis
Price Target
No Data
